LONG-TERM SAFETY OF HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS

https://storage.unitedwebnetwork.com/files/1099/7c611d4bf0d5ec1833565ab1f9ef489a.pdf
LONG-TERM SAFETY OF HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS
Jeffrey
Ha
Swapnil Hiremath shiremath@toh.ca University of Ottawa Division of Nephrology, Department of Medicine Ottawa
Min Jun mjun@georgeinstitute.org.au The George Institute for Global Health Renal and Metabolic Division Sydney
Suetonia Palmer suetonia.palmer@otago.ac.nz University of Otago Department of Medicine Christchurch
David Wheeler d.wheeler@ucl.ac.uk University College London Department of Renal Medicine London
Daniel Coyne dcoyne@wustl.edu Washington University School of Medicine Division of Nephrology St. Louis
Vlado Perkovic vlado.perkovic@unsw.edu.au University of New South Wales Faculty of Medicine & Health Sydney
Sunil Badve s.badve@unsw.edu.au The George Institute for Global Health Renal and Metabolic Division Sydney